U.S. pulls back on asbestos protections again—this time in your cosmetics

Core Viewpoint - The Trump administration has withdrawn a proposed FDA rule requiring testing for asbestos in talc-based cosmetics, signaling a shift in regulatory focus away from asbestos concerns [2][8]. Regulatory Changes - The proposed rule, initiated by the Biden administration, aimed to mandate manufacturers to test for asbestos in cosmetics and maintain compliance records [3][4]. - The FDA's withdrawal is attributed to the need to reconsider the best methods for addressing asbestos exposure and to develop a more comprehensive approach to cosmetics regulation [5][9]. Health Concerns - Asbestos exposure is linked to serious health issues, including lung cancer and mesothelioma, with no safe level of exposure established by health agencies [3][11]. - Consumer advocates express concern that the withdrawal of the testing requirement could lead to increased risk of asbestos contamination in cosmetics, which poses a significant health threat [11]. Industry Implications - The FDA plans to propose a new rule under the Modernization of Cosmetics Regulation Act of 2022, which aims to identify safer alternatives to asbestos and reduce related illnesses [8][9]. - The current regulatory environment reflects a broader trend of rolling back protections against asbestos, contrasting with the Biden administration's previous efforts to ban its use [10]. Global Context - The U.S. remains out of step with over 50 countries that have completely banned asbestos, raising concerns about the safety of cosmetics manufactured in regions where asbestos is still permitted [10].